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Familial	Mediterranean	Fever	(FMF)	is	an	autosomal	reces-
sive	 inherited	disease	characterized	by	recurrent	episodes	of	
fever,	 peritonitis,	 sinovitis,	 pleuritis,	 and	 rarely	 pericarditis	
and	meningitis	(1).	It	is	common	in	ethnic	groups	originating	
from	around	 the	Mediterranean	Sea.	The	 incidence	of	FMF	
and	 the	 frequency	 of	 FMF-associated	 amyloidosis	 are	 quite	
high	in	Turkey	(1,	2).	The	diagnosis	of	FMF	is	based	on	typi-
cal	 clinical	 findings	 supported	 by	 family	 history,	 laboratory	
findings,	and	identification	of	genetic	mutations.	Regular	col-
chicine	treatment	reduces	the	frequency	and/or	severity	of	the	
inflammatory	episodes	and	prevents	the	development	of	amy-
loidosis	(1).
Congenital	Byler	 Syndrome	 (progressive	 familial	 intrahe-
patic	 cholestasis)	 is	 another	 autosomal	 recessive	 inherited	
disease	presenting	during	infancy	or	childhood,	characterized	
by	the	defective	secretion	of	bile	acids	leading	to	cholestatic	
progressive	liver	failure.	Ursodeoxycholic	acid	(UDCA)	and	
partial	external	biliary	diversion	may	be	palliative	treatment	
modalities,	whereas	liver	transplantation	is	curative	(3).
Clinically	 apparent	 amyloid	 goiter	 rarely	 develops	 due	 to	
secondary	amyloidosis	associated	with	inflammatory	diseas-
es.	Amyloid	deposits	in	the	thyroid	gland	were	first	reported	
by	von	Rokitansky	in	1855,	and	enlargement	of	thyroid	caused	
by	amyloid	accumulation	was	first	described	by	Beckman	in	
1858	and	termed	“amyloid	goiter”	by	Eiselberg	in	1904	(4).
	We	aim	to	present	a	rare	case	of	a	patient	with	two	inherited	
diseases,	Byler	Syndrome	and	FMF,	who	had	received	 liver	
and	 kidney	 transplantations,	 and	 then	 developed	 a	 rapidly	
growing	large	amyloid	goiter	related	to	secondary	amyloido-
sis	of	FMF.
CASE PRESENTATION
In	May	2013,	a	24-year-old	man	presented	to	our	outpatient	
clinic	with	the	complaints	of	an	enlargement	in	his	throat	and	
feeling	compression	in	the	supine	position	for	approximately	
two	years.	He	had	no	additional	complaints	except	for	occa-
sional	episodes	of	diarrhea,	secondary	to	the	use	of	colchicine	
since	childhood.
His	family	history	revealed	that	his	parents	had	consanguin-
eous	marriage	and	his	sibling	with	cholestasis	with	a	partial	
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clinical	improvement	with	UDCA	therapy	had	died	in	early	in-
fancy.	His	medical	history	revealed	that	he	had	been	followed	
at	Pediatric	Gastroenterology	and	General	Surgery	clinics	with	
a	diagnosis	of	congenital	Byler	Syndrome.	At	the	age	of	3,	he	
underwent	liver	transplantation	from	a	live	donor	(his	mother).
A	diagnosis	of	Familial	Mediterranean	Fever	was	made	in	
2000	based	on	the	presence	of	typical	clinical	symptoms,	in-
cluding	 abdominal	 pain,	 intermittent	 episodes	 of	 fever,	 and	
arthritis	 that	 responded	 to	 colchicine	 treatment.	 Before	 the	
diagnosis,	he	had	undergone	unnecessary	appendectomy.	Ge-
netic	testing	for	the	FMF	gene	was	not	performed.	Because	of	
persistent	proteinuria,	a	renal	biopsy	was	performed	in	2005	
and	revealed	secondary	amyloidosis.	A	second	renal	biopsy,	
performed	in	2007	to	rule	out	other	causes	of	his	massive	pro-
teinuria,	confirmed	amyloidosis	as	 the	only	cause.	Although	
colchicine	 therapy	was	prescribed	at	a	dose	of	1	gram	three	
times	a	day,	he	was	not	compliant	with	treatment,	and	his	renal	
disease	 progressed	 to	 severe	 nephrotic	 syndrome.	 In	March	
2011,	medical	nephrectomy	was	performed	with	high	dose	in-
domethacin	and	he	then	underwent	renal	replacement	therapy	
with	hemodialysis.	Renal	transplantation	from	the	same	live	
donor	was	performed	in	July	2011.
Upon	his	admission	to	our	clinic	in	May	2013,	his	physical	
examination	 revealed	 that	 he	 had	 a	 bilateral	 palpable,	 pain-
less,	 and	multinodular	 thyroid	gland.	According	 to	 the	clas-
sification	of	World	Health	Organization,	his	thyroid	gland	was	
classified	as	Grade	3.	Thyroid	functions	were	normal.	Table	1	
shows	his	initial	laboratory	findings.
On	 thyroid	 ultrasonography,	 the	 right	 lobe	 of	 the	 thyroid	
gland	was	 41x33x72	mm,	 the	 left	 lobe	was	 25x25x62	mm	
and	 the	 isthmus	was	7.8	mm.	There	were	hypo-echoic	solid	
nodules	 with	 smooth	 contours	 at	 the	 posterior	 lower	 zone	
(11x8	 mm)	 and	 middle-lower	 zone	 (26x13x24	 mm	 and	
16x11	mm)	of	the	right	lobe.	A	10x7	mm,	hypo-echoic	solid	
nodule	 with	 smooth	 contours	 was	 detected	 in	 the	 posterior	
middle	zone	of	the	left	lobe.	A	5x3	mm	anechoic	cystic	nodule	
with	smooth	contours	and	a	 thin	wall	was	seen	on	 the	 right	
lateral	isthmus	(Figure	1).	Fine	needle	aspiration	biopsy	of	the	
26x13x24	mm	hypo-echoic	nodule	at	the	middle	lower	zone	
of	the	right	lobe	revealed	amyloid-negative	staining.
In	June	2013,	the	patient	underwent	total	thyroidectomy	due	
to	bilateral	enlargement	of	 the	 thyroid	gland	and	compression	
symptoms.	 There	 were	 no	 post-operative	 complications	 and	
levothyroxin	was	 initiated	 for	 the	 treatment	 of	 post-operative	
hypothyroidism.	Histopathological	examination	of	the	thyroid-
ectomy	specimen	revealed	deposits	of	extracellular	amyloid	and	
dense	adipose	metaplasia,	which	are	diagnostic	for	amyloid	goi-
ter	(Figure	2).	Informed	consent	was	obtained	from	the	patient	
for	this	case	report.	This	case	report	was	approved	by	the	Baskent	
University	Institutional	Review	Board	(Project	No:	KA14/117).
DISCUSSION
Familial	Mediterranean	Fever	 has	 an	 autosomal	 recessive	
inheritance	with	gene	polymorphism	and	can	 result	 in	amy-
loidosis.	Accumulation	of	amyloid	A	protein	(AA)	occurs	in	
secondary	amyloidosis	associated	with	FMF.	Colchicine	treat-
ment	 prevents	 and	 retards	 episodes	 as	 well	 as	 renal	 failure	
when	it	is	initiated	early	after	FMF	diagnosis	and	used	regu-
larly	(5).	In	a	multicenter	study	by	the	Turkish	FMF	Working	
Group	conducted	on	2838	cases,	it	was	reported	that	the	mean	
age	at	onset	of	FMF	was	9	years	and	the	mean	age	at	diagnosis	
was	16	years	(6).	The	most	frequent	gene	mutation	(52%)	in	
FMF	patients	is	M694V,	and	12.9%	of	patients	are	reported	to	have	
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	 Initial	values	 Normal	range
TSH	(µIU/mL)	 0.423	 0.27-4.2
Free	T4	(ng/dL)	 1.32	 0.7-1.48
Free	T3	(pg/mL)	 2.55	 1.71-3.71
Anti-microsomal	antibody	 0.2	 <5.61	
(anti-TPO)	(IU/mL)
Anti-thyroglobulin	(IU/mL)	 1.71	 0-4.11
PTH	(pg/mL)	 68.99	 15-68
Creatinine	 0.93	 0.5-1.3
CRP	(sensitive)	(mg/L)	 7.46	 0-10
Hemoglobin	(g/dL)	 13.1	 12-16
ALT	(U/L)	 27	 0-41
TSH:	thyroid-stimulating	hormone;	Free	T4:	free	thyroxine;	Free	T3:	free	triio-
dothyronine;	PTH:	parathyroid	hormone;	CRP:	C-reactive	protein;	ALT:	alanine	
aminotransferase
TABLE 1. Patient	initial	laboratory	findings
FIG. 1. Ultrasonography of the heterogeneous right lobe of the 
enlarged thyroid gland.
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amyloidosis	that	might	cause	chronic	renal	failure.	In	this	study,	
it	was	emphasized	that	renal	failure	due	to	systemic	amyloidosis	
associated	with	FMF	could	be	prevented	by	early	diagnosis	(6).
In	communities	with	high	rates	of	consanguineous	marriage	
and	FMF	carriage,	children	are	likely	to	be	carriers	or	born	with	
the	illness.	As	the	rate	of	FMF	carriage	is	high	in	the	Turkish	
population	and	consanguineous	marriages	are	common,	the	risk	
of	multiple	inherited	diseases	is	high	(2,	6).	In	our	case,	the	co-
existence	of	Byler	Syndrome	and	FMF	disease	led	to	double	or-
gan	failure,	and	liver	and	kidney	transplantations	were	required.	
Although	our	case	was	diagnosed	with	FMF	when	he	was	11,	
unfortunately,	amyloidosis	could	not	be	prevented	due	to	the	ir-
regular	use	of	colchicine.	The	diagnosis	of	Byler	Syndrome	had	
been	based	on	clinical	findings	and	histopathological	features	
on	liver	biopsy,	but	was	not	confirmed	by	genetic	analysis	in	
our	patient.	To	the	best	of	our	knowledge,	there	is	no	previously	
published	case	of	concurrent	FMF	and	Byler	Syndrome	in	the	
literature,	which	makes	our	patient	a	unique	case.
Amyloid	 goiter	 can	 occur	 in	 association	 with	 primary	 or	
secondary	 amyloidosis.	Amyloid	 accumulation	was	 demon-
strated	in	the	thyroid	gland	of	80%	of	patients	with	secondary	
amyloidosis	in	autopsy	examination	(4).	Systemic	amyloido-
sis	was	detected	in	84	(7.6%)	of	1100	FMF	patients	followed	
in	a	university	clinic	in	Turkey;	amyloid	goiter	was	detected	
in	only	three	(0.27%)	of	them	(7).
Amyloid	goiter	is	usually	asymptomatic.	Although	thyroid	
functions	were	normal	in	our	case,	the	patient	complained	of	
his	enlarged	thyroid,	which	caused	compression	on	his	throat.	
The	histopathological	findings	after	thyroidectomy	were	con-
sistent	with	amyloid	goiter	and	adipose	metaplasia	associated	
with	systemic	amyloidosis.	(8-10).
In	conclusion, when	goiter	is	detected	in	patients	with	a	his-
tory	of	 systemic	 amyloidosis	 and	 especially	 in	 cases	with	 a	
rapidly	growing	goiter	without	any	functional	abnormalities,	
amyloid	goiter	should	be	considered	first.	Fine	needle	aspira-
tion	biopsy	may	be	inadequate,	as	was	the	case	in	our	patient.	
Histopathological	 examination	 of	 thyroidectomy	material	 is	
required	for	a	definitive	diagnosis	(8-10).
We	think	that	this	case	is	unique	and	has	important	implica-
tions	for	primary	care	physicians	and	healthcare	professionals	
since:	1)	it	draws	attention	to	the	risk	of	concurrent	hereditary	
disorders	as	a	consequence	of	consanguineous	marriage,	2)	it	
emphasizes	the	importance	of	early	diagnosis	and	continuous	
treatment	of	FMF,	and	3)	it	increases	awareness	regarding	the	
diagnosis	of	amyloid	goiter	in	patients	with	FMF.
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FIG. 2. Amyloid accumulation at interfollicular sites and focal lipid 
infiltration in the interstitium (crystal violet, original magnification 
x200)
